
A recombinant humanized monoclonal IgG1 antibody that binds to and inhibits the biologic activity of human vascular endothelial growth factor (VEGF). Bevacizumab contains human framework regions and the complementarity-determining regions of a murine antibody that binds to VEGF. Bevacizumab is produced in a Chinese Hamster Ovary mammalian cell expression system in a nutrient medium containing the antibiotic gentamicin and has a molecular weight of approximately 149 kilodaltons.
Vyberte, čo potrebujete, a my sa vám ozveme

Kazdy rok stoja maturanti pred dolezitym rozhodnutim, aky studijny odbor si vybrat a ake povolanie c...
Čítať viac
V poslednom obdobi coraz castejsie pocuvame o viruse RSV. Spolu s virusom chripky a koronavirusom pa...
Čítať viac
V roku 2007 získali Nobelovu cenu za fyziológiu alebo medicínu Mario R. Capecchi (USA), Sir Martin E...
Čítať viac